Clinical Trial Update: GW873140 In Combination With Combivir In HIV Infected Subjects [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating GW873140 in combination with Combivir in HIV-infected subjects has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• COMBIVIR (Lamivudine and Zidovudine)
• GW873140

Snippet

Sponsor: ViiV Healthcare | Conditions: Infection, Human Immunodeficiency Virus I, HIV Infection | Phase 2 | Status: TERMINATED